Twist Bioscience TWST
NASDAQ TWST
$153.10 +3.04 (+2.03%)
As of: Aug 27, 2026 · 3:59 PM EDT

Twist Bioscience (TWST) Restructuring Costs (2019 - 2026)

Twist Bioscience (TWST) posted quarterly Restructuring Costs of $7.2 million for Q1 2026, down 67.98% quarter-over-quarter from $22.5 million in Q4 2019.

Twist Bioscience (TWST) Restructuring Costs (2019 - 2026) Analysis & Trends

Twist Bioscience (TWST) has reported Restructuring Costs for 2 consecutive years, with $7.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Restructuring Costs changed N/A year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $7.2 million (changed N/A YoY), while the FY2020 annual figure was $22.5 million, changed N/A from the prior year.
  • Restructuring Costs slipped to $7.2 million in Q1 2026 per TWST's latest filing, from $22.5 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $7.2 million in Q1 2026 and bottomed at $7.2 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Twist Bioscience 9.55 Bn 9.38 Bn 62.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.21 Mn
Sep 30, 2023 332,000.00
Jun 30, 2023 9.05 Mn
Dec 31, 2019 22.50 Mn